Home > EMA sees 'possible link' between J&J vaccine and blood clots

News
EMA sees 'possible link' between J&J vaccine and blood clots

Description

Sabine Straus, chair of the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), says there is a "possible link" between the occurrence of blood clots and vaccination with Johnson & Johnson's Covid-19 vaccine. SOUNDBITE

Added on the 20/04/2021 17:52:40 - Copyright : AFPTV - First images

To customise your video :

Generic export code

More videos on the subject

EU health officials investigating link between AstraZeneca COVID-19 vaccine and blood clots

Les Aléas du direct : Emission du mardi 21 octobre 2014

11/03/2021 - Wochit
EMA approves Pfizer vaccine on 12-15 year-olds

The Hague, May 28 (EFE).- The European Medicines Agency recommended Friday the use of Pfizer/BioNTech Covid-19 vaccines in adolescents aged 12-15 years.The EMA scientific committee’s advice will be sent to the European Commission, which will issue the final approval.FOOTAGE COURTESY OF EBS.SOUNDBITES OF MARCO CAVALERI.

28/05/2021 - EFE Inglés
Experts Reveal There Is No Link Between Alcohol and COVID Vaccine Efficacy

05/05/2021 - Wochit
AstraZeneca vaccine benefits increase with age: EMA

The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age, despite links to blood clots. SOUNDBITE

23/04/2021 - AFPTV - First images
EMA review finds AstraZeneca benefits still outweigh risks

The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits still outweigh the risks for adults despite links to blood clots. SOUNDBITE

23/04/2021 - AFPTV - First images